ARANESP

DARBEPOETIN ALFA · Amgen, Inc

Drug timelines are a Plus or Pro feature.

70 regulatory and trial events tracked for ARANESP, covering 2007-03-09 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Comparison Between Darbapoeitin Alpha and Roxadustat in CKD-related Anemia